Acute hyperglycaemia and oxidative stress generation

Diabetic Medicine

Volumn 14, Issue SUPPL. 3, 1997, Pages

  Ceriello, A ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Acute hyperglycaemia; Antioxidants; Oxidative stress; TRAP

Indexed keywords

ANTIOXIDANT; FREE RADICAL; HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1;

ARTICLE; ATHEROSCLEROSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; OXIDATIVE STRESS; PATHOGENESIS; POSTPRANDIAL STATE; VASOCONSTRICTION;

FREE RADICALS; HUMANS; HYPERGLYCEMIA; INTERCELLULAR ADHESION MOLECULE-1; OXIDATIVE STRESS;

EID: 0030837471     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199708)14:3+3.0.CO;2-R     Document Type: Article

References (46)

1. Christiansen JS, Frandsen M, Parving HH. Effects of intravenous glucose infusion on renal function in normal man and insulin-dependent diabetics. Diabetologia 1981; 21: 368-373.
2. Bohlen HG, Lash JM. Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilatation of normal rat arterioles. Am J Physiol 1993; 265: H219-H225.
3. Patel V, Rassam SMB, Chen HC, Kohner EM. Oxygen reactivity in diabetes mellitus: effect of hypertension and hyperglycaemia. Clin Sci 1994; 86: 689-695.
4. Sullivan PM, Davies EG, Caldwell G, Morris AH, Kohner EM, Retinal blood flow during hyperglycaemia. Invest Ophthalmol Visual Sci 1990; 31: 2041-2045.
5. Gregersen G. Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients. Diabetologia 1968; 4: 273-277.
6. Gonder-Frederick LA, Cox DJ, Bobbitt SA, Pennebaker JW. Mood changes associated with blood glucose fluctuations in insulin-dependent diabetes mellitus. Health Psychol 1989; 8: 45-59.
7. Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric: motility. Gastroenterology 1988; 94: 739-744.
8. Oster-Jorgensen E, Pedersen SA, Larsen ML. The influence of induced hyperglycaemia on gastric emptying in healthy humans. Scand J Clin Lab Invest 1990; 50: 831-836.
9. Groop LC, De Fronzo RA, Luizi L, Melander A. Hyperglycaemia and absorption of sulphonylurea drugs. Lancet 1989; 2: 129-130.
10. Hoffman A, Fisher Y, Gilhar D, Raz I. The effect of hyperglycaemia on the absorption of glibenclamide in patients with non-insulin dependent diabetes mellitus. Eur J Clin Pharmacol 1994; 47: 53-55.
11. de Boer SY, Masclee AAM, Lam WF, Lamers CBHW. Effect of acute hyperglycemia on esophageal motility and lower esophageal sphincter pressure in humans. Gastroenterology 1992; 103: 775-780.
12. O'Sullivan JJ, Conroy RM, Robinson K, Hickey N, Mulcahy R. In hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991; 14: 758-760.
13. Gokhroo R, Mittal SR. Electrocardiographic correlates of hyperglycemia in acute myocardial infarction. Int J Cardiol 1989; 22: 267-269.
14. Duckrow RB, Beard DC, Brennan RW. Regional cerebral blood flow decrease during chronic and acute hyperglycemia. Stroke 1987; 18: 52-58.
15. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 1993; 36: 1119-1125.
16. Jones RL, Peterson CM. Reduced fibrinogen survival in diabetes mellitus: a reversible phenomenon. J Clin Invest 1979; 63: 485-493.
17. Jones RL. Fibrinopeptide A in diabetes mellitus: relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes. Diabetes 1985; 34: 836-841.
18. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Marchi E, Torella R. Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. Metabolism 1989; 38: 1162-1163.
19. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Torella R. Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia 1988; 31: 889-891.
20. Ceriello A, Giugliano D, Quatraro A, Consoli G, Stante A, Dello Russo P, D'Onofrio F. Induced hyperglycemia alters antithrombin III activity but not its plasma concentration in healthy normal subjects. Diabetes 1987; 36: 320-323.
21. Ceriello A, Giugliano D, Quatraro A, Marchi E, Barbanti M, Lefebvre PJ. Evidence for a hyperglycaemia-dependent decrease of antithrombin-thrombin complex formation in humans. Diabetologia 1990; 33: 163-167.
22. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 1990; 173: 932-939.
23. Wolff SP, Dean RT. Glucose auto-oxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 1987; 245: 243-250.
24. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993; 42: 801-813.
25. Ceriello A, Giacomello R, Stel G, Motz E, Taboga C, Tonutti L, et al. Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes 1995; 44: 924-928.
26. Ceriello A, Quatraro A, Giugliano D. Diabetes mellitus and hypertension. The possible role of hyperglycaemia through oxidative stress. Diabetologia 1993; 36: 265-266.
27. Ceriello A, Quatraro A, Caretta F, Varano R, Giugliano D. Evidence for a possible role of oxygen free radicals in the abnormal functional arterial vasomotion in insulin dependent diabetes. Diabete Metab 1990; 16: 318-322.
28. Ceriello A, Giugliano D, Quatraro A, Lefebvre PJ. Antioxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci 1991; 81: 739-742.
29. Ceriello A, Motz E, Cavarape A, Lizzio S, Russo A, Quatraro A, et al. Hyperglycemia counterbalances the anti-hypertensive effect of glutathione in diabetic patients. Evidence linking hypertension and glycemia through the oxidative stress in diabetes mellitus. J Diab Compl 1997; in press.
30. Marfella R, Verrazzo G, Acampora R, La Marca C, Giunta R, Lucarelli C, et al. Glutathione reverses systemic hemodynamic changes by acute hyperglycemia in healthy subjects. Am J Physiol 1995; 268: E1167-E1173.
31. The Diabetes Control and Complications Trials (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
32. Ruosladti E. Integrins. J Clin Invest 1991; 187: 1-5.
33. Lopes-Virella MF, Virella G. Immune mechanism of atherosclerosis in diabetes mellitus. Diabetes 1992; 41 (suppl 2): 86-91.
34. Blann AD, McCollum CN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost 1994; 72: 151-154.
35. Ceriello A, Falleti E, Bortolotti N, Motz E, Cavarape A, Russo A, et al. Increased circulating ICAM-1 levels in Type-2 diabetic patients: the possible role of metabolic control and oxidative stress. Metabolism 1996; 45: 498-501.
36. Ceriello A, Falleti E, Bortolotti N, Motz E, Cavarape A, Russo A, et al. Increased circulating ICAM-1 levels in Type-2 diabetic patients: the possible role of the oxidative stress and metabolic control (Abstract). Diabetologia 1995; 38 (suppl. 1): 154.
37. Halliwell B, Gutteridge JMC. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990; 280: 1-8.
38. Ghiselli A, Serafini M, Maiani G, Azzini E, Ferro-Luzzi A. A fluorescence-based method for measuring total plasma antioxidant capability. Free Rad Biol Med 1995; 18: 29-36.
39. Asayama K, Uchida N, Nakane T, Hayashibe H, Dobashi K, Amemiya S, et al. Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Rad Biol Med 1993; 15: 597-602.
40. Tsai EC, Hirsch IB, Brunzell JD, Chait A. Lower plasma peroxyl radical trapping capacity and higher susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994; 43: 1010-1014.
41. Ceriello A, Bortolotti N, Falleti E, Taboga C, Tonutti L, Crescentini A, et al. Total Radical-trapping Antioxidant Parameter in non-insulin dependent diabetic patients. Diabetes Care 1997; 20: 194-197.
42. Bortolotti N, Falleti E, Crescentini A, Ceriello A, Motz E, Cavarape A, et al. Diminuzone della capacità antiossidante plasmatica durante curva da carico di glucosio in pazienti diabetici. 27th Meeting of the Italian Society of Clinical Biochemistry, Riva del Garda (TN), 3-6 October 1995. G109A.
43. Ceriello A. Acute hyperglycemia and oxidative stress generation. 32nd Research Symposium sponsored by the American Diabetes Association and European Association for the Study of Diabetes. The Role of Oxidants and Antioxidant Therapy in Diabetic Complications. Orlando, Florida, 15-17 November 1996.
44. Santiago JV. Lessons from the diabetes control and complications trial. Diabetes 1993; 42: 1549-1554.
45. American Diabetes Association. Position Statement. Implications of the Diabetes Control and Complications Trial. Diabetes 1993; 42: 1555-1558.
46. 1c to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995; 44: 968-983.